Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details


Education & Training

  • Fellowship Program, Pediatric Allergy/Immunology, 1984
    Oklahoma Children's Hospital
  • Fellowship Program, Clinical Immunology, 1982
    Memorial Sloan-Kettering Cancer Center
  • Fellowship Program, Immunology, 1980
    McMaster University Med. Ctr.
  • Residency Program, Pediatrics, 1978
    McMaster University Med. Ctr.
  • Residency Program, Pediatrics, 1977
    Hospital for Sick Children-Toronto
  • Internship Program, Pediatrics, 1976
    Hospital for Sick Children-Toronto
  • MD, 1975
    University of Saskatchewan College of Medicine
  • BS, 1971
    University of Saskatchewan

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Rheumatology

Awards & Recognition

  • Top Doctors No Va Magazine (2017, 2016, 2015)

National Provider ID: 1902916182


Lawrence K. Jung, M.D., is chief of the Division of Rheumatology at Children's National Health System. Dr. Jung has more than 30 years of experience treating pediatric patients with rheumatologic disorders.

Dr. Jung has been involved in translational and clinical research for the last 30 years. He has received funding from the National Institutes of Health and other agencies for studies in immunology and rheumatology. He is the chief editor for pediatric rheumatology content for eMedicine.

Before joining Children’s National, Dr. Jung was on the Board of Directors for the Arthritis Foundation in Nebraska and organized an annual Arthritis Camp for children with arthritis. He is now actively involved with the Washington Chapter of the Arthritis Foundation's patient education and advocacy efforts. He is Emeritus Professor of Pediatrics at the George Washington University School of Medicine and Health Sciences. 

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • OncoImmune
  • Am. Board of Pediatrics

Abatacept in children with juvenile idiopathic arthritis A randomized doubleblind placebocontrolled withdrawal trial

(2008) Lancet

Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis

(2008) New England Journal of Medicine

Crosslinking CD7 on Myeloblasts Results in GranulocyteMacrophage ColonyStimulating Factor Production

(1996) Blood 88

Decreased Bone Strength in HLAB27 Transgenic Rat Model of Spondyloarthropathy

(2007) Rheumatology

Expression of bonespecific alkaline phosphatase on human B cells

(2008) Cellular Immunology

Juvenile Arthritis

(2001) Manual of Clinical Problems in Pediatrics

Juvenile Rheumatoid Arthritis

(1994) Manual of Clinical Problems in Pediatrics

Leflunomide or Methotrexate for Juvenile Rheumatoid Arthritis

(2005) New England Journal of Medicine

Other Rheumatic and Vasculitic Disorders

(2001) Manual of Clinical Problems in Pediatrics

Premature atherosclerosis in pediatric systemic lupus erythematosus Risk factors for increased carotid intimamedia thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort

(2009) Arthritis and Rheumatology